Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild Hyperglycemia
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
This study is not being conducted in the United States. Key long-term clinical studies have
shown that people with type 2 diabetes should try to achieve overall blood glucose levels as
close to normal as possible. The purpose of this study is to assess the safety and
effectiveness of vildagliptin, an unapproved drug, compared to placebo in lowering overall
blood glucose levels in people with type 2 diabetes who have not been previously treated with
drug therapy to lower their blood sugar and whose blood glucose levels are close to normal.